ArticleInternational journal of hematology2023

Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy.

Chia-Yau Chang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.